# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Ehlers-Danlos Syndrome
- **MONDO ID:**  (if available)
- **Category:** Genetic

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Ehlers-Danlos Syndrome**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** perplexity
**Generated:** 2025-12-16T06:41:17.021391

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC7288446/
2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6723307/
3. https://www.orpha.net/en/disease/detail/287
4. https://en.wikipedia.org/wiki/Ehlers%E2%80%93Danlos_syndrome
5. https://pubmed.ncbi.nlm.nih.gov/31409039/
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC3827857/
7. https://ehlersdanlosnews.com/news/extracellular-matrix-dysregulated-vascular-eds-patients-skin-cells/
8. https://en.wikipedia.org/wiki/Unfolded_protein_response
9. https://academic.oup.com/immunohorizons/article/9/10/vlaf044/8256436
10. https://pubmed.ncbi.nlm.nih.gov/38183136/
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC3666557/
12. https://pubmed.ncbi.nlm.nih.gov/40972649/
13. https://pmc.ncbi.nlm.nih.gov/articles/PMC12180213/
14. https://onlinelibrary.wiley.com/doi/full/10.1002/ajmg.a.63957
15. https://onlinelibrary.wiley.com/doi/abs/10.1002/humu.24456
16. https://pmc.ncbi.nlm.nih.gov/articles/PMC10695548/
17. https://www.ncbi.nlm.nih.gov/gtr/conditions/C2700425/
18. https://www.ncbi.nlm.nih.gov/books/NBK1462/
19. https://pmc.ncbi.nlm.nih.gov/articles/PMC12065848/
20. https://jeanniedibon.com/eds-osteoporosis/
21. https://pmc.ncbi.nlm.nih.gov/articles/PMC8621259/
22. https://aacrjournals.org/cancerdiscovery/article/14/7/1324/746125/Senescence-Defines-a-Distinct-Subset-of
23. https://pubmed.ncbi.nlm.nih.gov/32162201/
24. https://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.63857
25. https://pmc.ncbi.nlm.nih.gov/articles/PMC9022617/
26. https://pmc.ncbi.nlm.nih.gov/articles/PMC12365377/
27. https://pmc.ncbi.nlm.nih.gov/articles/PMC6051899/
28. https://www.ehlers-danlos.com/2017-eds-classification-non-experts/mast-cell-disorders-ehlers-danlos-syndrome-2/
29. https://www.ehlers-danlos.com/dysautonomia/
30. https://www.ehlers-danlos.com/wp-content/uploads/2022/03/EDS-ECHO-Clinicians-6A-Session-8.pdf
31. https://pubmed.ncbi.nlm.nih.gov/34807422/
32. https://www.ehlers-danlos.com/speds/
33. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.02537/full
34. https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.717535/full
35. https://www.ncbi.nlm.nih.gov/books/NBK541503/
36. https://pubmed.ncbi.nlm.nih.gov/27745832/
37. https://pmc.ncbi.nlm.nih.gov/articles/PMC6435442/
38. https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0161347
39. https://www.nature.com/articles/s41392-025-02249-0
40. https://pmc.ncbi.nlm.nih.gov/articles/PMC5979373/
41. https://pubmed.ncbi.nlm.nih.gov/37827202/
42. https://pmc.ncbi.nlm.nih.gov/articles/PMC10806136/
43. https://pmc.ncbi.nlm.nih.gov/articles/PMC6557237/
44. https://onlinelibrary.wiley.com/doi/full/10.1111%2Fexd.14191
45. https://anatomypubs.onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0177(200006)218:2%3C235::AID-DVDY2%3E3.0.CO;2-G
46. https://www.ncbi.nlm.nih.gov/books/NBK549814/
47. https://pmc.ncbi.nlm.nih.gov/articles/PMC10455523/
48. https://now.aapmr.org/ehler-danlos-syndrome/
49. https://columbiasurgery.org/conditions-and-treatments/connective-tissue-disease
50. https://path.upmc.edu/cases/case504/dx.html
51. https://clinicaterapeutica.it/ojs/index.php/1/article/download/254/215/955
52. https://pmc.ncbi.nlm.nih.gov/articles/PMC11389543/
53. https://pmc.ncbi.nlm.nih.gov/articles/PMC3053004/
54. https://pubmed.ncbi.nlm.nih.gov/7378285/
55. https://www.ehlers-danlos.com/skin/
56. https://journals.physiology.org/doi/abs/10.1152/physrev.00003.2017